Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2154
Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Contribution of efflux pump in drug resistance of fluoroquinolone resistant Mycobacterium tuberculosis isolates
6th World Congress on Biotechnology
Richa Kumari, Rajneesh Tripathi, Alok Prakash Pandey, Prince Chaubey, Pallavi Sinha and Shampa Anupurba
Banaras Hindu University, India
Posters-Accepted Abstracts: J Biotechnol Biomater
Abstract
Fluoroquinolones (FQs) are widely used second line anti tuberculosis drug. Extensive use of FQs has increased the incidence of resistance in Mycobacterium tuberculosis. Apart from mutation in the drug target site i.e., gyr A and gyr B the resistance may develop due to active efflux pump. In this study, we evaluated the role of the efflux pumps in fluoroquinolone resistance by using efflux inhibitors carbonyl cyanide m-chlorophenyl hydrazone (CCCP) which acts by decreasing the trans-membrane electrochemical gradient and verapamil, a calcium channel blocker in clinical isolates of M. tuberculosis. A total of 50 fluoroquinolone resistant M. tuberculosis clinical isolates were tested by Resazurin micro titer assay (REMA) to observe the changes in minimum inhibitory concentration (MIC) in presence and absence of efflux inhibitors using standard strain H37Rv. The MIC levels showed 2-8 fold reduction in presence of CCCP (10/50 20%) and verapamil (12/50 24%). Reduction in MIC was observed in (15/50 30%) strains when both the inhibitors were used simultaneously. Our findings suggest that an active efflux pump could be a major contributor in development of resistance against fluoroquinolones. Significant reduction in MIC indicates the involvement of Major Facilitator Super Family (MFS) family and ATP Binding Cassette (ABC) transporters which are inhibited by CCCP and verapamil respectively.Biography
Email: richaimsbhu@gmail.com
